Interleukine-2 (IL-2) Plus Semaglutide in Alzheimer's Disease

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Alzheimer Dementia (AD)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Houston Methodist Research Institute, Houston, Texas, United States
Contact: Study coordinator (Alireza Faridar, MD) · afaridar@houstonmethodist.org · 713-441-1150
Study coordinator · afaridar@houstonmethodist.org

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Innate Immunity Stimulation Via TLR9 in Early AD

Mild Cognitive Impairment · Alzheimer Dementia

Abroad (travel likely)RecruitingPHASE1

New York, United States

A Study to Evaluate the Efficacy and Safety of TTYP01 Tablets in Early Symptomatic Alzheimer's Disease

AD · Early Alzheimer's Disease

Abroad (travel likely)RecruitingPHASE2

Chongqing, China

Combined Brain Stimulation and Methylphenidate Treatment for Apathy in Dementia

Alzheimer s Disease · Alzheimer Dementia (AD) · Alzheimer Dementia

Abroad (travel likely)RecruitingPHASE2

Toronto, Canada

Comprehensive Assessment of Neurodegeneration and Dementia

Dementia · Mild Cognitive Impairment (MCI) · Subjective Cognitive Impairment

Abroad (travel likely)Recruiting

Calgary, Canada · Edmonton, Canada